Hiroaki Kurihara
Yokohama, 2418515, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Clinical Robustness of FDG-PET/CT Quantitative Metrics Post-Harmonization in a Multicenter, Cross-Scanner Setting.
Journal: Tomography (Ann Arbor, Mich.)
Published: May 25, 2026
First-in-human phase I study of hypoxia-targeting 64Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64).
Journal: ESMO open
Published: January 04, 2026
Local therapy with hypoxia-targeting radiopharmaceutical [64Cu]Cu-ATSM in high-grade glioma patient-derived xenograft models.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: September 15, 2025
Prognostic value of FDG-PET/CT findings in mucosal melanoma of the head and neck treated with carbon ion radiotherapy.
Journal: Annals of nuclear medicine
Published: January 30, 2025
[Measurement of Airborne Radioactivity in the Inpatient Room after Administering [64Cu]Cu-ATSM to Patients].
Journal: Kaku igaku. The Japanese journal of nuclear medicine
Published: January 29, 2025
Efficacy of radioactive hypoxia-targeting therapeutic agent 64Cu-ATSM on recurrent malignant glioma: a study protocol for a phase-III, investigator-sponsored, randomized controlled trial.
Journal: Japanese journal of clinical oncology
Published: October 10, 2024
Comparison of dose distribution with and without reflecting heterogeneous boron distribution using 18F-BPA positron emission tomography in boron neutron capture therapy.
Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
Published: September 18, 2024
64Cu2+ Complexes of Tripodal Amine Ligands' In Vivo Tumor and Liver Uptakes and Intracellular Cu Distribution in the Extrahepatic Bile Duct Carcinoma Cell Line TFK-1: A Basic Comparative Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 29, 2024
A case of pelvic squamous cell carcinoma of unknown primary origin that responded well to radiotherapy and nivolumab.
Journal: Radiology case reports
Published: November 23, 2023
Trace Metal Impurities Effects on the Formation of [64Cu]Cu-diacetyl-bis(N4-methylthiosemicarbazone) ([64Cu]Cu-ATSM).
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 15, 2023
SMARCA4-deficient tumors in the adrenal gland and small intestines: A rare case report.
Journal: Radiology case reports
Published: September 19, 2023
Process to Remove the Size Variants Contained in the Antibody-Chelator Complex PCTA-NCAB001 for Radiolabeling with Copper-64.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 22, 2023
Last Updated: 09/26/2026